Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway

• Shui-ping Zhao ,

  Contributed equally to this work with: Shui-ping Zhao, Rong Li

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliation Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

  ⨯
• Rong Li ,

  Contributed equally to this work with: Shui-ping Zhao, Rong Li

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Department of Stomatology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

  ⨯
• Wen Dai,

  Roles Investigation, Methodology

  Affiliation Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

  ⨯
• Bi-lian Yu,

  Roles Writing – review & editing

  Affiliation Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

  ⨯
• Lu-zhu Chen,

  Roles Investigation, Methodology

  Affiliation Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

  ⨯
• Xian-sheng Huang

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: initialhxs@163.com.

  Affiliation Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

  http://orcid.org/0000-0003-4988-425X

  ⨯